Plasma Derived Medicine Market Size And Trends
The global plasma-derived medicine market was valued at approximately USD 15.96 billion in 2023 and is anticipated to reach USD 37.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 8.05% from 2024 to 2034. The rising demand for plasma-derived medicines is driven by their critical applications in addressing various plasma protein dysfunctions and deficiencies.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5302
Plasma-Derived Medicine Market Trends
In September 2024, Viromed Medical AG plans to acquire all shares of ActivCell Group, with negotiations expected to begin immediately. This acquisition could facilitate the integration of plasma medicine into routine practice through ActivCell Group’s CellPen device line, which effectively utilizes cold plasma technology in portable, cordless “pens.”
In December 2023, PlasmaGen Biosciences, a biopharmaceutical company, raised approximately $27 million (around ₹225 crore) in equity funding. This investment will support the Bengaluru-based firm’s expansion of its plasma product line.
In May 2023, the New York Blood Center, Inc. (NYBC) invested $50 million in its inaugural fund, NYBC Ventures, aimed at driving innovation in cellular therapies, enabling technologies, and blood-related sectors.
Opportunities in the Plasma-Derived Medicine Market
The plasma-derived medicine market is poised for growth, particularly due to the aging population and advancements in healthcare that enhance diagnosis and treatment. Identifying new therapeutic applications for plasma-derived medicines will be crucial. There is currently no viable alternative to intravenous immunoglobulin (IVIG), and its therapeutic scope may expand to include neurological conditions such as neuropathic pain, chronic fatigue syndrome, and post-polio syndrome. Additionally, researchers are investigating potential applications for albumin in treating conditions like sepsis, cirrhosis, stroke, Alzheimer’s disease, and malaria.
Challenges Facing the Plasma-Derived Medicine Market: High Costs
Plasma-derived medicines involve costly manufacturing processes that utilize human plasma, which is a complex raw material. These products tend to be expensive due to stringent safety measures, high-quality raw materials, and advanced technologies required for their production.
Top Companies in the Plasma Derived Medicine Market
- Biotest AG
- Kameda Pharmaceuticals
- ADMA Biologics
- Shanghai RAAS
- Kedrion
- China Biologic Products Holdings
- Bio Products Laboratory
- CSL Limited
- Octapharma AG
- LFB
- Takeda
- Fusion Healthcare
- SK Plasma
- Grifols, S.A
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/plasma-derived-medicine-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5302
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare